BA
Bacil Pharma Limited
BACPHAR.BO · BSE
₹23.99 -0.91% (-₹0.22)
1M +34.18%
Market Cap ₹347.5M
P/E Ratio 52.77x
Div. Yield -
ROE 2.56%
Analýza
AI report o byznysu, financích, ocenění, sentimentu, zprávách a rizicích - napsaný během několika minut.
Piotroski F-Score Weak
2/9Valuation
33 /100
Expensive P/B 1.40x
P/E 52.77x
EV/FFO N/A
Growth
0 /100
Declining Book val. growth 7.44%
FCF growth N/A
EPS growth N/A
Profitability
-
N/A Op. margin N/A
Gross margin N/A
FCF margin N/A
Quality
7 /100
Poor ROA 2.40%
ROIC 2.59%
Asset turnover 0.00x
Debt
72 /100
Low Current ratio 0.68x
Debt/Equity 0.00x
Debt/Assets N/A
Stability
19 /100
Unstable Profitable years 1
Beta 0.36x
EPS volatility 900.43%
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na BACPHAR.BO
Online
Sector
Healthcare
Industry
Medical - Pharmaceuticals
CEO
Ganpat Dhondu Salekar
Employees
2
Headquarters
Mumbai